Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 7—July 2026

Dispatch

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022–2024

Pavitra RoychoudhuryComments to Author , Erica Wetzler, Anna Elias-Warren, Katherine L. Hoffman, Alex Harteloo, Hyeong Geon Kim, Kevin Kong, Hong Xie, Jolene Gov, Margaret G. Mills, Collrane Frivold, Madison Hollcroft, Mark Drummond, Tara Hatchie, Erica Clark, Brenna Ehmen, Peter D. Han, Luis Gamboa, Sally Grindstaff, Jeremy Stone, Alexander L. Greninger, Lea M. Starita, Christina Lockwood, Janet A. Englund, Marco Carone, Ana A. Weil, Sacha L. Reich, Richard A. Mularski, Mark A. Schmidt, Jennifer L. Kuntz, Allison L. Naleway, and Helen Y. Chu
Author affiliation: Fred Hutchinson Cancer Center, Seattle (P. Roychoudhury); University of Washington, Seattle, Washington, USA (P. Roychoudhury, E. Wetzler, A. Elias-Warren, K.L. Hoffman, A. Harteloo, H.G. Kim, K. Kong, H. Xie, J. Gov, M.G. Mills, C. Frivold, M. Hollcroft, M. Drummond, T. Hatchie, E. Clark, B. Ehmen, P.D. Han, L. Gamboa, S. Grindstaff, J. Stone, A.L. Greninger, L.M. Starita, C. Lockwood, J.A. Englund, M. Carone, A.A. Weil, H.Y. Chu); Brotman Baty Institute for Precision Medicine, Seattle (L. Gamboa); Seattle Children’s Research Institute, Seattle (J.A. Englund); Kaiser Permanente Center for Health Research, Portland, Oregon, USA (S.L. Reich, R.A. Mularski, M.A. Schmidt, J.L. Kuntz, A.L. Naleway)

Main Article

Table 2

Characteristics of households and household contacts in study of household transmission of enterovirus D68, Washington and Oregon, United States, 2022–2024*

Characteristics Potential secondary transmission† Unlikely secondary transmission‡ Total
No. households
7
28
35
Household density§
2–4 persons 6 (85.7) 24 (85.7) 30 (85.7)
>5 persons
1 (14.3)
4 (14.3)
5 (14.3)
Housing type
House, condo, or townhouse 7 (100) 27 (96.4) 34 (97.1)
Missing
0
1 (3.6)
1 (2.9)
Household enrollment
Median no. participants (range) 3 (2–4) 3 (2–4) 3 (2–4)
No children <5 y 5 (71.4) 17 (60.7) 22 (62.9)
Child <5 y, but no childcare 1 (14.3) 2 (7.1) 3 (8.6)
Child <5 y in childcare¶
1 (14.3)
9 (32.1)
10 (28.6)
Income >$100,000
3 (42.9)
22 (78.6)
25 (71.4)
Smoker in household
1 (14.3)
2 (7.1)
3 (8.6)
Study site
Kaiser Permanente Northwest 4 (57.1) 12 (42.9) 16 (44.4)
University of Washington
3 (42.9)
16 (57.1)
19 (54.3)
No. household contacts
15
51
66
No. swab samples tested from symptomatic participants
14
20
34
Median age, y (range)
42 (2–48)
38 (3–49)
38.5 (2–49)
Age range
6 mo–1 y 0 0 1 (1.4)
2–4 y 1 (6.7) 1 (2.0) 1 (1.7)
5–12 y 3 (20.0) 17 (33.3) 22 (31.4)
13–50 y
11 (73.3)
33 (64.7)
45 (64.3)
Female sex at birth
9 (60.0)
30 (58.8)
39 (59.1)
Sex
F 9 (60.0) 29 (56.9) 38 (57.6)
M 6 (40.0) 21 (41.2) 27 (40.9)
Other
0
1 (2.0)
1 (1.5)
Race or ethnicity
Asian 2 (13.3) 2 (3.9) 4 (6.1)
White 11 (73.3) 44 (86.3) 55 (83.3)
Multiracial 2 (13.3) 5 (9.8) 7 (10.6)
Hispanic
0
4 (7.8)
4 (6.1)
Any smoking
1 (6.7)
2 (3.9)
3 (4.5)
Any underlying conditions#
10 (66.7)
23 (45.1)
33 (50.0)
Masking in public
Any 14 (93.3) 48 (94.1) 62 (93.9)
Never 1 (6.1) 3 (5.9) 4 (6.1)

*Values are no. (%) except as indicated. ARI, acute respiratory illness; EV, enterovirus; HPIV, human parainfluenza virus; RSV, respiratory syncytial virus. †Occurring when EV-D68 is detected in a secondary household member 1–14 days after index case. ‡Unlikely secondary transmission defined as occurring when only 1 EV-D68 case was detected in the household or when >2 EV-D68 cases were in a household but secondary case detected >14 days after index case. §Household density represents the number of household members regardless of enrollment in the study; thus, numbers might be greater than the number of participants enrolled in the study, if not all household members were enrolled. ¶Daycare or school attendance among >1 child <5 years in the household as reported at enrollment. #Underlying conditions include asthma, chronic obstructive pulmonary disease (including chronic bronchitis and emphysema), sleep apnea, heart disease, congenital heart disease, heart failure, Down syndrome, hypertension (high blood pressure), diabetes (high blood sugar), liver condition, weak or failing kidneys, cancer or malignancy, arthritis, stroke, deep vein thrombosis or pulmonary embolism, sickle cell disease or thalassemia, weakened immune system, depression, anxiety, thyroid issues, or other health diagnosis.

Main Article

Page created: May 28, 2026
Page updated: June 23, 2026
Page reviewed: June 23, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external